Anumana, an nference venture, Receives FDA 510(k) Clearance on ECG-AI LEF for Early Detection of Low EF

nference | Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease.

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

Download Our One-Pager